Latest Regulation News

D3 Energy has achieved a significant milestone with its maiden certified methane and helium reserves at ER315 in South Africa, enabling an early submission of its Production Right application. The reserves cover a small portion of the acreage but signal substantial upside potential.

Macquarie Group Limited reported a 5% increase in FY25 profit to A$3.715 billion, declaring a higher dividend and announcing a key CFO transition. The group also outlined a strategic divestment and cautious outlook for FY26.

Macquarie Group reported a decline in net profit contribution for the first quarter of FY26, driven by mixed performances across its divisions, while maintaining a robust capital surplus and announcing a key CFO transition.

Regis Healthcare has agreed to acquire four premium aged care homes in South-East Queensland from Rockpool, adding 600 beds and boosting its portfolio to 72 homes. The $135 million deal is expected to be earnings accretive in FY26.

Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.

Bowen Coking Coal’s initial attempt to defer state royalty payments has been declined by the Queensland Revenue Office, prompting plans for a revised proposal amid ongoing debt restructuring efforts.

Macarthur Minerals has updated its rights issue prospectus, introducing a cap on the underwriter's shareholding and revising key offer terms. These changes aim to balance funding needs with shareholder control and regulatory compliance.

Elsight Limited has raised A$60 million through a strongly supported placement, marking a milestone with consecutive record revenues and cash flow breakeven. The company is poised to capitalize on surging defence budgets and expanding drone markets with a robust pipeline of opportunities.

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.

Mitchell Services Limited reported a robust fourth quarter with strong cash flow driving a significant net debt reduction, while its Loop decarbonisation joint venture gains momentum with new contracts.

Condor Energy has secured a 12-month extension for its Technical Evaluation Agreement in Peru’s Tumbes Basin, underpinning its exploration and commercialisation plans backed by significant prospective oil and gas resources.